AORT Artivion, Inc.
21.61USD-1.05%Mkt Cap: 1.05B $P/E: —1d ago
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; Carbon…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap1.05B USD
Enterprise Value1.40B USD
Revenue (TTM)471.47M USD
Gross Profit284.23M USD
Net Income (TTM)9.77M USD
Revenue/Share9.85 USD
Last Price21.61 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.8K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)29.18
PEG643.75
EV/EBITDA21.90
EV/Revenue2.96
P/S2.26
P/B2.39
EPS (TTM)-0.07
EPS (Forward)0.75
52W Range
19.168% of range48.25
52W High48.25 USD
52W Low19.16 USD
Profitability
Gross Margin64.40%
Oper. Margin9.01%
EBITDA Margin13.51%
Profit Margin2.21%
ROE2.18%
ROA1.10%
Growth
Revenue Growth11.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF39.88M USD
CapEx (TTM)39.04M USD
FCF Margin2.78%
FCF Yield1.24%
Net Debt330.65M USD
Net Debt/EBITDA5.19
Balance Sheet
Debt/Equity0.57
Current Ratio3.47
Quick Ratio1.76
Book Value/Sh9.15 USD
Cash/Share1.59 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield0.74%
Payout Ratio0.00%
Ex-Div DateDec 9, 2015
Pay Date—
Splits
Last Split3:2
Split DateDec 28, 2000
Analyst Consensus
Rating—
Target (Mean)42.15 USD
Upside (mean)+95.0%
Target Range38.00 USD – 48.00 USD
38.00+95.0% to mean48.00
# Analysts8
Ownership
Shares Out.48.76M
Float46.28M
Insiders4.29%
Institutions96.42%
Short Interest
Short Ratio5.2d
Short % Float8.09%
Short % Out.6.74%
Shares Short3.28M
Short (prev mo.)2.75M
Technical
SMA 5025.77 (-16.2%)
SMA 20031.45 (-31.3%)
Beta1.22
S&P 52W Chg16.45%
Avg Vol (30d)590.46K
Avg Vol (10d)514.76K
Technical Indicators
RSI (14)31.8
MACD-1.0122
MACD Signal-0.9136
MACD Hist.-0.0986
BB Upper25.72 USD
BB Middle23.41 USD
BB Lower21.09 USD
BB Width19.78%
ATR (14)1.008 USD
Vol Ratio (20d)0.56x